A network-based pathway-expanding approach for pathway analysis

BackgroundPathway analysis combining multiple types of high-throughput data, such as genomics and proteomics, has become the first choice to gain insights into the pathogenesis of complex diseases. Currently, several pathway analysis methods have been developed to study complex diseases. However, these methods did not take into account the interaction between internal and external genes of the pathway and between pathways. Hence, these approaches still face some challenges. Here, we propose a network-based pathway-expanding approach that takes the topological structures of biological networks into account.ResultsFirst, two weighted gene-gene interaction networks (tumor and normal) are constructed integrating protein-protein interaction(PPI) information, gene expression data and pathway databases. Then, they are used to identify significant pathways through testing the difference of topological structures of expanded pathways in the two weighted networks. The proposed method is employed to analyze two breast cancer data. As a result, the top 15 pathways identified using the proposed method are supported by biological knowledge from the published literatures and other methods. In addition, the proposed method is also compared with other methods, such as GSEA and SPIA, and estimated using the classification performance of the top 15 expanded pathways.ConclusionsA novel network-based pathway-expanding approach is proposed to avoid the limitations of existing pathway analysis approaches. Experimental results indicate that the proposed method can accurately and reliably identify significant pathways which are related to the corresponding disease.

[1]  E. Birney,et al.  Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.

[2]  David Haussler,et al.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..

[3]  Bo Xu,et al.  Murine Colon Proteome and Characterization of the Protein Pathways , 2011 .

[4]  R. Clarke,et al.  Mammary Stem Cells and Breast Cancer—Role of Notch Signalling , 2007, Stem Cell Reviews.

[5]  Wei Feng Zhu,et al.  Network-guided genetic screening for metastasis-related microRNA-200c in breast cancer , 2013 .

[6]  Masatoshi Nomura,et al.  Hedgehog Signaling Pathway is a New Therapeutic Target for Patients with Breast Cancer , 2004, Cancer Research.

[7]  Hanqing Xue,et al.  Network-based methods for identifying critical pathways of complex diseases: a survey. , 2016, Molecular bioSystems.

[8]  F. Bellisle,et al.  Decreased taste sensitivity in cancer patients under chemotherapy , 2004, Supportive Care in Cancer.

[9]  Denis Thieffry,et al.  RegulonDB: a database on transcriptional regulation in Escherichia coli , 1998, Nucleic Acids Res..

[10]  Weida Tong,et al.  Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling , 2005, BMC Bioinformatics.

[11]  K. Trier,et al.  Glycosaminoglycans in human breast cancer , 1988, Acta obstetricia et gynecologica Scandinavica.

[12]  Saranya Chumsri,et al.  Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3 , 2014, Breast Cancer Research and Treatment.

[13]  Jennifer Lin,et al.  Intakes of calcium and vitamin D and breast cancer risk in women. , 2006, Archives of internal medicine.

[14]  V. Marzo,et al.  Targeting the endocannabinoid system in cancer therapy: A call for further research , 2002, Nature Medicine.

[15]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[16]  S. Lovell,et al.  Protein-protein interaction networks and biology—what's the connection? , 2008, Nature Biotechnology.

[17]  F. Sotgia,et al.  Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. , 2014, Seminars in cancer biology.

[18]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[19]  Yves Deville,et al.  Relevant subgraph extraction from random walks in a graph , 2006 .

[20]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Malats,et al.  Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Wei Gao,et al.  Association between female breast cancer and cutaneous melanoma , 2004, International journal of cancer.

[23]  Mads Melbye,et al.  Risk for Subsequent Cancer after Diagnosis of Basal-Cell Carcinoma: A Population-Based, Epidemiologic Study , 1996, Annals of Internal Medicine.

[24]  Marwan Alsaedi,et al.  Basal Cell Carcinoma of the Nipple–Areola Complex , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[25]  A. Docquier,et al.  [Vitamin B6 and cancer: from clinical data to molecularly mechanisms]. , 2011, Bulletin du cancer.

[26]  Woon-Puay Koh,et al.  Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. , 2003, Cancer research.

[27]  R H Hruban,et al.  Genetics of pancreatic cancer. From genes to families. , 1998, Surgical oncology clinics of North America.

[28]  Haruo Tanaka,et al.  The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells. , 2009, Anticancer research.

[29]  F. Sotgia,et al.  Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells , 2011, Cancer biology & therapy.

[30]  Jian Huang,et al.  Regularized gene selection in cancer microarray meta-analysis , 2009, BMC Bioinformatics.

[31]  Peter J. Woolf,et al.  GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.

[32]  Zhiyuan Hu,et al.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.

[33]  Q Ping Dou,et al.  Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. , 2010, Current drug targets.

[34]  Kenneth H. Buetow,et al.  The PathOlogist: an automated tool for pathway-centric analysis , 2011, BMC Bioinformatics.

[35]  Georgios A. Pavlopoulos,et al.  Caipirini: using gene sets to rank literature , 2012, BioData Mining.

[36]  T. Rohan,et al.  Vitamin D, Calcium, and Breast Cancer Risk: A Review , 2006, Cancer Epidemiology Biomarkers & Prevention.

[37]  Zhen-Yu You,et al.  Analyzing the differentially expressed genes and pathway cross‐talk in aggressive breast cancer , 2015, The journal of obstetrics and gynaecology research.

[38]  H. Ganther,et al.  Comparison of selenium and sulfur analogs in cancer prevention. , 1992, Carcinogenesis.

[39]  S. Hankinson,et al.  Night Work and Risk of Breast Cancer , 2006, Epidemiology.

[40]  Jia Chen,et al.  One-carbon metabolism and breast cancer: an epidemiological perspective. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[41]  Zhongming Zhao,et al.  GenRev: exploring functional relevance of genes in molecular networks. , 2012, Genomics.

[42]  F. Sotgia,et al.  Ketone bodies and two-compartment tumor metabolism: Stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells , 2012, Cell cycle.

[43]  Seon-Young Kim,et al.  PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..

[44]  I. Leray,et al.  Promotion of Cancer Cell Invasiveness and Metastasis Emergence Caused by Olfactory Receptor Stimulation , 2014, PloS one.

[45]  Li Jin,et al.  A systematic characterization of genes underlying both complex and Mendelian diseases. , 2012, Human molecular genetics.

[46]  R. Clarke,et al.  Aberrant Activation of Notch Signaling in Human Breast Cancer , 2006 .

[47]  Feng Luo,et al.  Core and periphery structures in protein interaction networks , 2009, BMC Bioinformatics.

[48]  Taekyu Park,et al.  Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways , 2012, PloS one.

[49]  Rainer Breitling,et al.  Graph-based iterative Group Analysis enhances microarray interpretation , 2004, BMC Bioinformatics.

[50]  N. McLean,et al.  Basal Cell Carcinoma of the Nipple–Areola Complex , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[51]  Peter D. Karp,et al.  The MetaCyc Database , 2002, Nucleic Acids Res..

[52]  I. Jurisica,et al.  Unequal evolutionary conservation of human protein interactions in interologous networks , 2007, Genome Biology.

[53]  Susan J Henly,et al.  Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer. , 2005, Clinical journal of oncology nursing.

[54]  Guang Jia,et al.  Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers. , 2012, Journal of hazardous materials.

[55]  R. Kreienberg,et al.  Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. , 2008, Gynecologic oncology.

[56]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[57]  T. Bisogno,et al.  Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation* , 2022 .

[58]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[59]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  Pierangelo Orlando,et al.  Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1. , 2000, Endocrinology.

[61]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[62]  Peter D. Karp,et al.  The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases , 2007, Nucleic Acids Res..

[63]  Andrea M Dietrich,et al.  Taste and odor abnormalities in cancer patients. , 2009, The journal of supportive oncology.

[64]  Michael J. E. Sternberg,et al.  AMBIENT: Active Modules for Bipartite Networks - using high-throughput transcriptomic data to dissect metabolic response , 2013, BMC Systems Biology.

[65]  G L Johanning,et al.  Modulation of breast cancer cell adhesion by unsaturated fatty acids. , 1996, Nutrition.

[66]  R. Tibshirani,et al.  On testing the significance of sets of genes , 2006, math/0610667.

[67]  M. Maccarrone,et al.  The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis , 2003, Cell Death and Differentiation.

[68]  Gottfried Konecny,et al.  Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. , 2003, Journal of the National Cancer Institute.

[69]  Alexander Isaev,et al.  PyEvolve: a toolkit for statistical modelling of molecular evolution , 2004, BMC Bioinformatics.

[70]  K ITO,et al.  [STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. II. UPTAKE OF PYRIDOXINE DERIVATIVES BY TUMOR CELLS AND THE LIVER OF TUMOR-BEARING RATS]. , 1964, Gan.

[71]  G. L. Blackburn,et al.  The effect of cancer on nitrogen, electrolyte, and mineral metabolism , 1977, Cancer research.

[72]  F. Sotgia,et al.  Ketone body utilization drives tumor growth and metastasis , 2012, Cell cycle.

[73]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[74]  Y. Shibayama,et al.  Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. , 2006, Histology and histopathology.

[75]  F. De Ceuninck,et al.  YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. , 2001, Biochemical and biophysical research communications.

[76]  L. Esserman,et al.  A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. , 2011, JAMA.

[77]  Sangeeta Agrawal,et al.  Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. , 2007, Journal of pain and symptom management.

[78]  John S. Williams,et al.  Nitrogen mustard as adjunctive chemotherapy for breast carcinoma , 1975, The British journal of surgery.

[79]  Luca Aresu,et al.  Array-Based Comparative Genomic Hybridization Analysis Reveals Chromosomal Copy Number Aberrations Associated with Clinical Outcome in Canine Diffuse Large B-Cell Lymphoma , 2014, PloS one.

[80]  Dragana Nikitovic,et al.  Glycosaminoglycans: key players in cancer cell biology and treatment , 2012, The FEBS journal.

[81]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[82]  Manju Bansal,et al.  A novel method for prokaryotic promoter prediction based on DNA stability , 2005, BMC Bioinformatics.

[83]  J. Sparano,et al.  Chemotherapy in Patients with Anthracycline and Taxane-Pretreated Metastatic Breast Cancer: An Overview , 2013, Current Breast Cancer Reports.

[84]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[85]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[86]  H. Ji,et al.  A network-based gene-weighting approach for pathway analysis , 2011, Cell Research.

[87]  Thomas Abeel,et al.  Intelligent Systems for Molecular Biology and European Conference on Computational Biology , 2022 .

[88]  Juan Ni,et al.  Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[89]  R. Mendel,et al.  The biosynthesis of the molybdenum cofactors , 2014, JBIC Journal of Biological Inorganic Chemistry.

[90]  Yin Li,et al.  Identifying novel glioma associated pathways based on systems biology level meta-analysis , 2013, BMC Systems Biology.

[91]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[92]  Gary D Bader,et al.  Pathway and network analysis of cancer genomes , 2015, Nature Methods.

[93]  Daohai Zhang,et al.  Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer* , 2005, Molecular & Cellular Proteomics.

[94]  A. Bishayee,et al.  Terpenoids and breast cancer chemoprevention , 2009, Breast Cancer Research and Treatment.